Clorox Company (The) (CLX) Stock Analysis
Recovery setup
Consumer Defensive · Household & Personal Products
Sell if holding. At $97.05, A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: U.S. markets (86.0%); Concentration risk — Supplier: sole source or single-source suppliers.
Clorox manufactures and markets consumer and professional branded products across four segments — Health and Wellness, Household, Lifestyle, and International — with fiscal 2025 net sales of $7.1 billion and about 7,600 employees worldwide. Walmart represented 27% of fiscal 2025... Read more
Sell if holding. At $97.05, A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: U.S. markets (86.0%); Concentration risk — Supplier: sole source or single-source suppliers. Chart setup: Death cross but MACD improving, RSI 53. Score 5.1/10, high confidence.
Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 47d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
About Clorox Company (The)
About Clorox Company (The)
Walmart accounted for 27% of The Clorox Company's $7.1 billion in fiscal 2025 net sales, consistent with its 25-26% share in prior years; the five largest customers collectively represented approximately half of annual consolidated sales across all four reporting segments. Clorox generated 86% of net sales from U.S. markets in fiscal 2025 and employed about 7,600 people worldwide. Cleaning products contributed 44% of consolidated net sales — the single largest category — with bags and wraps at 15%, food products at 12%, and cat litter at 10%.
Clorox sells branded products through mass retailers, grocery chains, warehouse clubs, dollar stores, hardware centers, and e-commerce channels. Over 80% of sales come from brands holding the No. 1 or No. 2 market share position in their categories. Key raw material inputs include resin, non-woven fabrics, sodium hypochlorite, corrugated cardboard, soybean oil, and agricultural commodities sourced from U.S. and international suppliers — some of which are sole source or single-source, introducing supply disruption risk. The company uses supply contracts and forward-purchase agreements to manage commodity price volatility, though it acknowledges being highly exposed to changes in commodity prices including as a result of new tariffs. In February 2025, Clorox announced the wind-down of its Glad bags and wraps joint venture with The Procter & Gamble Company, with Clorox acquiring P&G's 20% interest at termination by January 31, 2026. A planned ERP system upgrade is expected to complete in the U.S. during fiscal 2026, with total transformational investment estimated at $570 to $580 million.
Show full overview
Walmart's 27% share of fiscal 2025 net sales — combined with the five largest customers accounting for approximately half of total revenue — concentrates Clorox in a small number of mass retailers with substantial shelf-space and pricing influence. The 10-K warns changes in large-customer strategies, such as shifting shelf space to private-label or demanding lower prices, may harm net sales or margins. In May 2026, the company disclosed via Form 8-K that CEO and Chair Linda Rendle will step down for health reasons, with the Board initiating a full CEO search while Ms. Rendle remains in role until a successor is named, adding leadership transition risk coinciding with the U.S. ERP implementation.
See also: Consumer Defensive · Household & Personal Products
From Clorox Company (The)'s most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated 2026-06-13Recent Developments — Clorox Company (The)
Material events (past 30 days)
- 8K May 28, 2026 HIGH Item 5.02: CEO and Chair Linda Rendle will step down for health reasons; Board initiating CEO search. Rendle remains Chair and CEO until successor appointed, then serves in advisory role. No successor named.
Latest news
- NEWS Clorox (CLX) Reports Q1: Everything You Need To Know Ahead Of Earnings - TradingView — TradingView neutral
- NEWS The Clorox Company (NYSE:CLX) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat — MarketBeat negative
- NEWS Clorox: Reduced Complexity Paves The Way For Multiple Expansion (NYSE:CLX) - Seeking Alpha — Seeking Alpha positive
- NEWS CLX Maintained by Jefferies -- Price Target Lowered to $139 - GuruFocus — GuruFocus negative
- NEWS Jefferies Financial Group Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price - MarketBeat — MarketBeat negative
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerWalmart27%10-K Item 1A: 'Net sales to the Company's largest customer, Walmart Stores, Inc. and its affiliates, were 27%, 25%, and 26% of consolidated net sales'
- MEDIUMCustomerfive largest customers10-K Item 1A: 'The Company's five largest customers accounted for nearly half of the Company's consolidated net sales for each of the fiscal years 2025, 2024, and 2023'
- HIGHGeographicU.S. markets86%10-K Item 1A: '86% of the Company's net sales were attributable to U.S. markets, including U.S. territories'
- MEDIUMProductCleaning products44%10-K Item 1: 'accounted for 10% or more of consolidated net sales ... Cleaning products| 44 | %'
- HIGHSuppliersole source or single-source suppliers10-K Item 1: 'some of which are sole source or single-source suppliers. Interruptions in the delivery of these materials could adversely impact the Company'
Material Events(8-K, last 90d)
- 2026-05-28Item 5.02HIGHCEO and Chair Linda Rendle will step down for health reasons; Board initiating CEO search. Rendle remains Chair and CEO until successor appointed, then serves in advisory role. No successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $97.05, A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: U.S. markets (86.0%); Concentration risk — Supplier: sole source or single-source suppliers. Chart setup: Death cross but MACD improving, RSI 53. Prior stop was $91.12. Score 5.1/10, high confidence.
Take-profit target: $98.72 (+2.0% upside). Prior stop was $91.12. Stop-loss: $91.12.
Concentration risk — Geographic: U.S. markets (86.0%); Concentration risk — Supplier: sole source or single-source suppliers; Analyst target reached - limited upside remaining.
Clorox Company (The) trades at a P/E of 15.7 (forward 15.4). TrendMatrix value score: 6.1/10. Verdict: Sell.
27 analysts cover CLX with a consensus score of 2.8/5. Average price target: $105.
What does Clorox Company (The) do?Clorox manufactures and markets consumer and professional branded products across four segments — Health and Wellness,...
Clorox manufactures and markets consumer and professional branded products across four segments — Health and Wellness, Household, Lifestyle, and International — with fiscal 2025 net sales of $7.1 billion and about 7,600 employees worldwide. Walmart represented 27% of fiscal 2025 consolidated net sales; the five largest customers accounted for approximately half of total sales.